Loading viewer...
investor_presentation
Format: PDF investor_presentation
Antengene Corporation Limited investor presentation from April 2024 outlining the company's pharmaceutical drug development efforts and clinical trial programs. The presentation covers investigational drug candidates and commercialization efforts focused on treating patients beyond borders.
investor_presentation
68 Pages
investor_presentation
3 Pages
Kroger
AIB Green Bond Investor Presentation June 2022
investor_presentationinvestor_presentation
25 Pages
AIB (Allied Irish Banks)
investor_presentation
SimCorp